| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.81e-06 | 2 | 34 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.81e-06 | 2 | 34 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 8.43e-06 | 3 | 34 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.78e-04 | 775 | 34 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.91e-04 | 15 | 34 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.79e-04 | 21 | 34 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.96e-04 | 229 | 34 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.89e-04 | 238 | 34 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 8.91e-04 | 26 | 34 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 8.91e-04 | 26 | 34 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | Notch binding | 9.62e-04 | 27 | 34 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.19e-03 | 30 | 34 | 2 | GO:0016417 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 1.81e-03 | 37 | 34 | 2 | GO:0016409 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.81e-03 | 37 | 34 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.41e-03 | 51 | 34 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.81e-03 | 54 | 34 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.95e-03 | 55 | 34 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.68e-03 | 60 | 34 | 2 | GO:0034212 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.26e-06 | 16 | 34 | 3 | GO:1900034 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.58e-05 | 4 | 34 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | embryo implantation | 1.91e-05 | 97 | 34 | 4 | GO:0007566 | |
| GeneOntologyBiologicalProcess | protein acylation | 2.92e-05 | 108 | 34 | 4 | GO:0043543 | |
| GeneOntologyCellularComponent | keratin filament | 6.52e-07 | 97 | 36 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 4.14e-05 | 227 | 36 | 5 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 8.32e-05 | 263 | 36 | 5 | GO:0045111 | |
| HumanPheno | Plantar crease between first and second toes | 9.25e-06 | 2 | 16 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 9.25e-06 | 2 | 16 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 9.25e-06 | 2 | 16 | 2 | HP:0001042 | |
| HumanPheno | Enamel hypoplasia | 1.18e-05 | 104 | 16 | 5 | HP:0006297 | |
| HumanPheno | Laryngeal cartilage malformation | 2.77e-05 | 3 | 16 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 2.77e-05 | 3 | 16 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 2.77e-05 | 3 | 16 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 2.77e-05 | 3 | 16 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 2.77e-05 | 3 | 16 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 2.77e-05 | 3 | 16 | 2 | HP:0005895 | |
| HumanPheno | Absent earlobe | 2.81e-05 | 20 | 16 | 3 | HP:0000387 | |
| HumanPheno | Hypoplasia of teeth | 3.00e-05 | 126 | 16 | 5 | HP:0000685 | |
| HumanPheno | Abnormal incisor morphology | 3.25e-05 | 62 | 16 | 4 | HP:0011063 | |
| HumanPheno | Trichiasis | 5.53e-05 | 4 | 16 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 5.53e-05 | 4 | 16 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 5.53e-05 | 4 | 16 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 5.53e-05 | 4 | 16 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 5.53e-05 | 4 | 16 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 5.53e-05 | 4 | 16 | 2 | HP:0031207 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 9.20e-05 | 5 | 16 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 9.20e-05 | 5 | 16 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 9.20e-05 | 5 | 16 | 2 | HP:0030421 | |
| HumanPheno | Large foramen magnum | 1.38e-04 | 6 | 16 | 2 | HP:0002700 | |
| HumanPheno | Deviated nasal septum | 1.92e-04 | 7 | 16 | 2 | HP:0004411 | |
| HumanPheno | Abnormality of the incisor | 2.86e-04 | 108 | 16 | 4 | HP:0000676 | |
| HumanPheno | Pilomatrixoma | 3.29e-04 | 9 | 16 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 3.29e-04 | 9 | 16 | 2 | HP:0002341 | |
| HumanPheno | Frontal hirsutism | 4.10e-04 | 10 | 16 | 2 | HP:0011335 | |
| HumanPheno | Abnormal dental enamel morphology | 4.33e-04 | 221 | 16 | 5 | HP:0000682 | |
| HumanPheno | Abnormal subclavian artery morphology | 5.00e-04 | 11 | 16 | 2 | HP:0031251 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 5.41e-04 | 53 | 16 | 3 | HP:0009906 | |
| HumanPheno | Dislocated radial head | 5.72e-04 | 54 | 16 | 3 | HP:0003083 | |
| HumanPheno | Abnormal odontoid tissue morphology | 6.10e-04 | 238 | 16 | 5 | HP:3000050 | |
| HumanPheno | Abnormality of the radial head | 6.71e-04 | 57 | 16 | 3 | HP:0003995 | |
| HumanPheno | Facial grimacing | 7.07e-04 | 13 | 16 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 7.07e-04 | 13 | 16 | 2 | HP:0010562 | |
| HumanPheno | Duplication of phalanx of hallux | 8.23e-04 | 14 | 16 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 8.23e-04 | 14 | 16 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 8.23e-04 | 14 | 16 | 2 | HP:0002697 | |
| HumanPheno | Abnormality of the humeroradial joint | 8.59e-04 | 62 | 16 | 3 | HP:0100744 | |
| HumanPheno | Duplication of phalanx of toe | 9.48e-04 | 15 | 16 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 9.48e-04 | 15 | 16 | 2 | HP:0007086 | |
| HumanPheno | Square face | 1.08e-03 | 16 | 16 | 2 | HP:0000321 | |
| HumanPheno | Dental malocclusion | 1.16e-03 | 156 | 16 | 4 | HP:0000689 | |
| HumanPheno | Premature thelarche | 1.22e-03 | 17 | 16 | 2 | HP:0010314 | |
| HumanPheno | Facial hirsutism | 1.37e-03 | 18 | 16 | 2 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 1.37e-03 | 18 | 16 | 2 | HP:0012842 | |
| HumanPheno | Atypical scarring of skin | 1.44e-03 | 74 | 16 | 3 | HP:0000987 | |
| MousePheno | abnormal craniofacial morphology | PCSK5 AMBRA1 NTN1 CLCN5 ATR LMX1A LYST ITGB4 CREBBP WNT1 EP300 TGFA | 1.22e-05 | 1372 | 30 | 12 | MP:0000428 |
| MousePheno | craniofacial phenotype | PCSK5 AMBRA1 NTN1 CLCN5 ATR LMX1A LYST ITGB4 CREBBP WNT1 EP300 TGFA | 1.22e-05 | 1372 | 30 | 12 | MP:0005382 |
| MousePheno | abnormal telencephalon morphology | 3.41e-05 | 812 | 30 | 9 | MP:0000787 | |
| MousePheno | abnormal forebrain morphology | 4.89e-05 | 1072 | 30 | 10 | MP:0000783 | |
| MousePheno | abnormal hindbrain morphology | 5.89e-05 | 485 | 30 | 7 | MP:0000841 | |
| MousePheno | abnormal head morphology | 7.11e-05 | 1120 | 30 | 10 | MP:0000432 | |
| MousePheno | abnormal facial morphology | 8.31e-05 | 910 | 30 | 9 | MP:0003743 | |
| MousePheno | abnormal vertebral column morphology | 1.88e-04 | 787 | 30 | 8 | MP:0004703 | |
| MousePheno | abnormal cerebral hemisphere morphology | 2.20e-04 | 599 | 30 | 7 | MP:0008540 | |
| MousePheno | abnormal metencephalon morphology | 2.28e-04 | 420 | 30 | 6 | MP:0000847 | |
| MousePheno | abnormal hair follicle morphology | 2.67e-04 | 148 | 30 | 4 | MP:0000377 | |
| MousePheno | lethality throughout fetal growth and development | 2.76e-04 | 435 | 30 | 6 | MP:0006208 | |
| MousePheno | abnormal spinal cord morphology | 2.84e-04 | 278 | 30 | 5 | MP:0000955 | |
| Domain | Keratin_B2 | 7.98e-07 | 40 | 34 | 4 | PF01500 | |
| Domain | - | 3.22e-06 | 2 | 34 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 3.22e-06 | 2 | 34 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.22e-06 | 2 | 34 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.22e-06 | 2 | 34 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 3.22e-06 | 2 | 34 | 2 | PF08214 | |
| Domain | KIX | 3.22e-06 | 2 | 34 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 3.22e-06 | 2 | 34 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 3.22e-06 | 2 | 34 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.22e-06 | 2 | 34 | 2 | IPR013178 | |
| Domain | DUF902 | 3.22e-06 | 2 | 34 | 2 | PF06001 | |
| Domain | - | 3.22e-06 | 2 | 34 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.22e-06 | 2 | 34 | 2 | IPR010303 | |
| Domain | KAT11 | 3.22e-06 | 2 | 34 | 2 | SM01250 | |
| Domain | - | 3.22e-06 | 2 | 34 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 3.22e-06 | 2 | 34 | 2 | IPR000197 | |
| Domain | KIX_dom | 3.22e-06 | 2 | 34 | 2 | IPR003101 | |
| Domain | Creb_binding | 3.22e-06 | 2 | 34 | 2 | PF09030 | |
| Domain | KIX | 3.22e-06 | 2 | 34 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 3.22e-06 | 2 | 34 | 2 | PS51727 | |
| Domain | KAP | 3.62e-06 | 58 | 34 | 4 | IPR002494 | |
| Domain | ZF_ZZ_2 | 4.41e-06 | 18 | 34 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.41e-06 | 18 | 34 | 3 | PS01357 | |
| Domain | ZZ | 4.41e-06 | 18 | 34 | 3 | PF00569 | |
| Domain | Znf_ZZ | 5.24e-06 | 19 | 34 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 5.24e-06 | 19 | 34 | 3 | SM00291 | |
| Domain | EGF_1 | 5.96e-06 | 255 | 34 | 6 | PS00022 | |
| Domain | EGF_2 | 7.43e-06 | 265 | 34 | 6 | PS01186 | |
| Domain | EGF_Lam | 3.47e-05 | 35 | 34 | 3 | SM00180 | |
| Domain | Laminin_EGF | 4.45e-05 | 38 | 34 | 3 | IPR002049 | |
| Domain | Nuc_rcpt_coact | 4.80e-05 | 6 | 34 | 2 | IPR009110 | |
| Domain | EGF-like_CS | 1.02e-04 | 261 | 34 | 5 | IPR013032 | |
| Domain | EGF_extracell | 1.76e-04 | 60 | 34 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.76e-04 | 60 | 34 | 3 | PF07974 | |
| Domain | - | 3.14e-04 | 73 | 34 | 3 | 2.60.120.260 | |
| Domain | EMI | 4.30e-04 | 17 | 34 | 2 | PS51041 | |
| Domain | Galactose-bd-like | 6.60e-04 | 94 | 34 | 3 | IPR008979 | |
| Domain | zf-DHHC | 7.95e-04 | 23 | 34 | 2 | PF01529 | |
| Domain | EGF_3 | 8.42e-04 | 235 | 34 | 4 | PS50026 | |
| Domain | EGF | 8.42e-04 | 235 | 34 | 4 | SM00181 | |
| Domain | DHHC | 9.40e-04 | 25 | 34 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 9.40e-04 | 25 | 34 | 2 | IPR001594 | |
| Domain | Bromodomain_CS | 1.02e-03 | 26 | 34 | 2 | IPR018359 | |
| Domain | EGF-like_dom | 1.04e-03 | 249 | 34 | 4 | IPR000742 | |
| Domain | EGF_LAM_2 | 1.36e-03 | 30 | 34 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.36e-03 | 30 | 34 | 2 | PS01248 | |
| Domain | Laminin_EGF | 1.84e-03 | 35 | 34 | 2 | PF00053 | |
| Domain | BROMODOMAIN_1 | 2.06e-03 | 37 | 34 | 2 | PS00633 | |
| Domain | Bromodomain | 2.17e-03 | 38 | 34 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.52e-03 | 41 | 34 | 2 | PS50014 | |
| Domain | BROMO | 2.65e-03 | 42 | 34 | 2 | SM00297 | |
| Domain | Bromodomain | 2.65e-03 | 42 | 34 | 2 | IPR001487 | |
| Domain | - | 2.65e-03 | 42 | 34 | 2 | 1.20.920.10 | |
| Domain | PSI | 2.90e-03 | 44 | 34 | 2 | IPR016201 | |
| Domain | PSI | 3.17e-03 | 46 | 34 | 2 | SM00423 | |
| Domain | WD40_repeat_CS | 3.26e-03 | 164 | 34 | 3 | IPR019775 | |
| Domain | WD40 | 1.15e-02 | 259 | 34 | 3 | PF00400 | |
| Domain | WD40 | 1.26e-02 | 268 | 34 | 3 | SM00320 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.81e-06 | 15 | 27 | 3 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.81e-06 | 15 | 27 | 3 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.81e-06 | 15 | 27 | 3 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.45e-06 | 16 | 27 | 3 | M8516 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 7.09e-06 | 66 | 27 | 4 | M101 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.52e-05 | 5 | 27 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.52e-05 | 5 | 27 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.52e-05 | 5 | 27 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.52e-05 | 5 | 27 | 2 | M48023 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.60e-05 | 34 | 27 | 3 | M39771 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.05e-05 | 38 | 27 | 3 | M27757 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.27e-05 | 6 | 27 | 2 | M22062 | |
| Pathway | PID_FOXM1_PATHWAY | 5.91e-05 | 40 | 27 | 3 | M176 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.38e-05 | 7 | 27 | 2 | MM1573 | |
| Pathway | PID_PS1_PATHWAY | 9.00e-05 | 46 | 27 | 3 | M70 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.82e-05 | 8 | 27 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 9.82e-05 | 8 | 27 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 9.82e-05 | 8 | 27 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 9.82e-05 | 8 | 27 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.26e-04 | 9 | 27 | 2 | M47451 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.38e-04 | 53 | 27 | 3 | MM15880 | |
| Pathway | PID_TAP63_PATHWAY | 1.46e-04 | 54 | 27 | 3 | M256 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.54e-04 | 55 | 27 | 3 | M39351 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.57e-04 | 10 | 27 | 2 | M27945 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.90e-04 | 59 | 27 | 3 | M39886 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.90e-04 | 59 | 27 | 3 | M261 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.92e-04 | 11 | 27 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.92e-04 | 11 | 27 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.92e-04 | 11 | 27 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.30e-04 | 12 | 27 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.30e-04 | 12 | 27 | 2 | M27765 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 3.15e-04 | 70 | 27 | 3 | M13266 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.17e-04 | 14 | 27 | 2 | M27808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 3.65e-04 | 15 | 27 | 2 | M47524 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 3.65e-04 | 15 | 27 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.17e-04 | 16 | 27 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.17e-04 | 16 | 27 | 2 | MM1420 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.17e-04 | 16 | 27 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 4.17e-04 | 16 | 27 | 2 | M27940 | |
| Pathway | BIOCARTA_PML_PATHWAY | 4.72e-04 | 17 | 27 | 2 | M4891 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.72e-04 | 17 | 27 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 4.72e-04 | 17 | 27 | 2 | M48025 | |
| Pathway | BIOCARTA_PML_PATHWAY | 5.30e-04 | 18 | 27 | 2 | MM1474 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 5.30e-04 | 18 | 27 | 2 | M26942 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 5.38e-04 | 84 | 27 | 3 | M1008 | |
| Pathway | PID_CMYB_PATHWAY | 5.38e-04 | 84 | 27 | 3 | M195 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 5.92e-04 | 19 | 27 | 2 | M46442 | |
| Pathway | KEGG_PROSTATE_CANCER | 6.38e-04 | 89 | 27 | 3 | M13191 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.57e-04 | 20 | 27 | 2 | M27881 | |
| Pathway | WP_TNFALPHA_SIGNALING | 7.02e-04 | 92 | 27 | 3 | M39662 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 7.25e-04 | 21 | 27 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 7.25e-04 | 21 | 27 | 2 | M27485 | |
| Pathway | REACTOME_KERATINIZATION | 7.26e-04 | 217 | 27 | 4 | M27640 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 7.97e-04 | 22 | 27 | 2 | MM1443 | |
| Pathway | BIOCARTA_G2_PATHWAY | 7.97e-04 | 22 | 27 | 2 | MM1365 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.97e-04 | 22 | 27 | 2 | MM1370 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 8.72e-04 | 23 | 27 | 2 | MM1527 | |
| Pathway | PID_NFKAPPAB_CANONICAL_PATHWAY | 8.72e-04 | 23 | 27 | 2 | M37 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 8.72e-04 | 23 | 27 | 2 | M2821 | |
| Pathway | KEGG_MELANOGENESIS | 9.21e-04 | 101 | 27 | 3 | M7761 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.21e-04 | 101 | 27 | 3 | M27253 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 9.21e-04 | 101 | 27 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 9.21e-04 | 101 | 27 | 3 | M39387 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 9.50e-04 | 24 | 27 | 2 | M16517 | |
| Pathway | BIOCARTA_G2_PATHWAY | 9.50e-04 | 24 | 27 | 2 | M8560 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 9.50e-04 | 24 | 27 | 2 | M13404 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NTN1 ITGB4 CREBBP WNT1 EP300 KRTAP1-4 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 9.64e-04 | 1432 | 27 | 9 | M509 |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.03e-03 | 25 | 27 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.12e-03 | 26 | 27 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.12e-03 | 26 | 27 | 2 | M32 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.18e-03 | 110 | 27 | 3 | M48259 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.29e-03 | 28 | 27 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.49e-03 | 30 | 27 | 2 | M207 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 1.49e-03 | 30 | 27 | 2 | M39580 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.49e-03 | 30 | 27 | 2 | M936 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 1.49e-03 | 30 | 27 | 2 | MM15831 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.69e-03 | 32 | 27 | 2 | M39521 | |
| Pathway | KEGG_CELL_CYCLE | 1.70e-03 | 125 | 27 | 3 | M7963 | |
| Pathway | PID_HIF2PATHWAY | 1.91e-03 | 34 | 27 | 2 | M44 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.02e-03 | 35 | 27 | 2 | M48246 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 2.21e-03 | 137 | 27 | 3 | M145 | |
| Pathway | PID_FRA_PATHWAY | 2.26e-03 | 37 | 27 | 2 | M65 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.38e-03 | 38 | 27 | 2 | M27255 | |
| Pathway | PID_ATR_PATHWAY | 2.51e-03 | 39 | 27 | 2 | M46 | |
| Pathway | PID_IFNG_PATHWAY | 2.63e-03 | 40 | 27 | 2 | M161 | |
| Pathway | WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA | 2.63e-03 | 40 | 27 | 2 | M48337 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.81e-03 | 149 | 27 | 3 | M27888 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.90e-03 | 42 | 27 | 2 | M17541 | |
| Pathway | PID_TCPTP_PATHWAY | 2.90e-03 | 42 | 27 | 2 | M91 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.92e-03 | 151 | 27 | 3 | M19428 | |
| Pathway | REACTOME_KERATINIZATION | 3.03e-03 | 153 | 27 | 3 | MM15343 | |
| Pathway | PID_HNF3A_PATHWAY | 3.18e-03 | 44 | 27 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.18e-03 | 44 | 27 | 2 | M27295 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.20e-03 | 325 | 27 | 4 | M12868 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.62e-03 | 47 | 27 | 2 | M7946 | |
| Pathway | PID_FANCONI_PATHWAY | 3.62e-03 | 47 | 27 | 2 | M1 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 3.77e-03 | 48 | 27 | 2 | M219 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.77e-03 | 48 | 27 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.77e-03 | 48 | 27 | 2 | M611 | |
| Pubmed | Polymorphisms in the human high sulfur hair keratin-associated protein 1, KAP1, gene family. | 9.66e-13 | 4 | 36 | 4 | 12228244 | |
| Pubmed | 3.79e-10 | 37 | 36 | 5 | 11279113 | ||
| Pubmed | p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint. | 1.02e-09 | 3 | 36 | 3 | 17272271 | |
| Pubmed | 1.22e-07 | 10 | 36 | 3 | 20347598 | ||
| Pubmed | 6.86e-07 | 17 | 36 | 3 | 18330926 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.04e-06 | 2 | 36 | 2 | 34845315 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19729597 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15860545 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.04e-06 | 2 | 36 | 2 | 24551300 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 33911074 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9018065 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24648406 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30135524 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.04e-06 | 2 | 36 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.04e-06 | 2 | 36 | 2 | 29217654 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20717166 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.04e-06 | 2 | 36 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.04e-06 | 2 | 36 | 2 | 29170789 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25893291 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11559821 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 1.04e-06 | 2 | 36 | 2 | 12646247 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 32576962 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19822209 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24522976 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.04e-06 | 2 | 36 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 1.04e-06 | 2 | 36 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.04e-06 | 2 | 36 | 2 | 34813504 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 1.04e-06 | 2 | 36 | 2 | 12696060 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 1.04e-06 | 2 | 36 | 2 | 36109165 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24639469 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 37816914 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.04e-06 | 2 | 36 | 2 | 11438528 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10918613 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31182547 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 35502657 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30635043 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 1.04e-06 | 2 | 36 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.04e-06 | 2 | 36 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.04e-06 | 2 | 36 | 2 | 27881443 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19272189 | ||
| Pubmed | Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1. | 1.04e-06 | 2 | 36 | 2 | 24100384 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 1.04e-06 | 2 | 36 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 1.04e-06 | 2 | 36 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 1.04e-06 | 2 | 36 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.04e-06 | 2 | 36 | 2 | 32690000 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9733868 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30953353 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21803292 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9811832 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 1.04e-06 | 2 | 36 | 2 | 33063428 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 34506759 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22177454 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.04e-06 | 2 | 36 | 2 | 39266679 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22303793 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.04e-06 | 2 | 36 | 2 | 34019788 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27881869 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 3.12e-06 | 3 | 36 | 2 | 14716005 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 3.12e-06 | 3 | 36 | 2 | 21967847 | |
| Pubmed | microRNA-449 is a putative regulator of choroid plexus development and function. | 3.12e-06 | 3 | 36 | 2 | 19056356 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 3.12e-06 | 3 | 36 | 2 | 19252086 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27903646 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12748286 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10075656 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24340053 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19273602 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 3.12e-06 | 3 | 36 | 2 | 22179676 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10842066 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 3.12e-06 | 3 | 36 | 2 | 26951377 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 21393509 | ||
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 3.12e-06 | 3 | 36 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 3.12e-06 | 3 | 36 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 3.12e-06 | 3 | 36 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 3.12e-06 | 3 | 36 | 2 | 12384703 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10350644 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 29145650 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 7870179 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19041714 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11038171 | ||
| Pubmed | Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. | 3.12e-06 | 3 | 36 | 2 | 12776737 | |
| Pubmed | Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage. | 3.12e-06 | 3 | 36 | 2 | 30836930 | |
| Pubmed | Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. | 3.12e-06 | 3 | 36 | 2 | 14759370 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10673036 | ||
| Pubmed | Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | 3.12e-06 | 3 | 36 | 2 | 12456660 | |
| Interaction | HOXB9 interactions | 4.64e-08 | 124 | 33 | 6 | int:HOXB9 | |
| Interaction | LCE1D interactions | 9.62e-08 | 70 | 33 | 5 | int:LCE1D | |
| Interaction | SMCP interactions | 1.77e-07 | 79 | 33 | 5 | int:SMCP | |
| Interaction | LCE3E interactions | 2.72e-06 | 60 | 33 | 4 | int:LCE3E | |
| Interaction | LCE3C interactions | 4.25e-06 | 67 | 33 | 4 | int:LCE3C | |
| Interaction | LCE1E interactions | 4.51e-06 | 68 | 33 | 4 | int:LCE1E | |
| Interaction | OTX1 interactions | 5.03e-06 | 155 | 33 | 5 | int:OTX1 | |
| Interaction | LCE3D interactions | 5.99e-06 | 73 | 33 | 4 | int:LCE3D | |
| Interaction | CRH interactions | 6.03e-06 | 22 | 33 | 3 | int:CRH | |
| Interaction | LCE2D interactions | 6.32e-06 | 74 | 33 | 4 | int:LCE2D | |
| Interaction | PLSCR4 interactions | 6.67e-06 | 75 | 33 | 4 | int:PLSCR4 | |
| Interaction | LCE3A interactions | 7.03e-06 | 76 | 33 | 4 | int:LCE3A | |
| Interaction | LCE4A interactions | 8.63e-06 | 80 | 33 | 4 | int:LCE4A | |
| Interaction | LCE2B interactions | 9.07e-06 | 81 | 33 | 4 | int:LCE2B | |
| Interaction | LCE1A interactions | 1.05e-05 | 84 | 33 | 4 | int:LCE1A | |
| Interaction | LCE1B interactions | 1.10e-05 | 85 | 33 | 4 | int:LCE1B | |
| Interaction | DMRT3 interactions | 1.20e-05 | 87 | 33 | 4 | int:DMRT3 | |
| Interaction | LCE2C interactions | 1.26e-05 | 88 | 33 | 4 | int:LCE2C | |
| Interaction | TFAP2D interactions | 1.32e-05 | 89 | 33 | 4 | int:TFAP2D | |
| Interaction | LCE5A interactions | 1.38e-05 | 90 | 33 | 4 | int:LCE5A | |
| Interaction | LCE1F interactions | 1.50e-05 | 92 | 33 | 4 | int:LCE1F | |
| Interaction | CYSRT1 interactions | 1.56e-05 | 511 | 33 | 7 | int:CYSRT1 | |
| Interaction | SHFL interactions | 1.85e-05 | 97 | 33 | 4 | int:SHFL | |
| Interaction | HOXA1 interactions | 2.16e-05 | 356 | 33 | 6 | int:HOXA1 | |
| Interaction | GNE interactions | 2.44e-05 | 104 | 33 | 4 | int:GNE | |
| Interaction | WNT11 interactions | 2.53e-05 | 35 | 33 | 3 | int:WNT11 | |
| Interaction | CHUK interactions | 2.99e-05 | 224 | 33 | 5 | int:CHUK | |
| Interaction | SDC3 interactions | 5.06e-05 | 44 | 33 | 3 | int:SDC3 | |
| Interaction | KRTAP4-2 interactions | 6.21e-05 | 132 | 33 | 4 | int:KRTAP4-2 | |
| Interaction | BCAM interactions | 7.44e-05 | 50 | 33 | 3 | int:BCAM | |
| Interaction | HOXB3 interactions | 9.29e-05 | 9 | 33 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 9.29e-05 | 9 | 33 | 2 | int:ARGFX | |
| Interaction | KRTAP9-2 interactions | 9.94e-05 | 149 | 33 | 4 | int:KRTAP9-2 | |
| Interaction | LDB2 interactions | 1.05e-04 | 56 | 33 | 3 | int:LDB2 | |
| Interaction | VASN interactions | 1.31e-04 | 160 | 33 | 4 | int:VASN | |
| Interaction | GLYAT interactions | 1.42e-04 | 11 | 33 | 2 | int:GLYAT | |
| Interaction | CREB5 interactions | 1.44e-04 | 164 | 33 | 4 | int:CREB5 | |
| Interaction | KRTAP12-1 interactions | 1.49e-04 | 63 | 33 | 3 | int:KRTAP12-1 | |
| Interaction | KRTAP5-4 interactions | 1.49e-04 | 63 | 33 | 3 | int:KRTAP5-4 | |
| Interaction | KRTAP5-11 interactions | 1.71e-04 | 66 | 33 | 3 | int:KRTAP5-11 | |
| Interaction | PHLDA1 interactions | 1.71e-04 | 66 | 33 | 3 | int:PHLDA1 | |
| Interaction | DOCK2 interactions | 1.71e-04 | 66 | 33 | 3 | int:DOCK2 | |
| Interaction | KRTAP5-3 interactions | 1.71e-04 | 66 | 33 | 3 | int:KRTAP5-3 | |
| Interaction | NR1D2 interactions | 1.78e-04 | 67 | 33 | 3 | int:NR1D2 | |
| Interaction | LRFN4 interactions | 1.78e-04 | 67 | 33 | 3 | int:LRFN4 | |
| Interaction | NR4A3 interactions | 1.95e-04 | 69 | 33 | 3 | int:NR4A3 | |
| Interaction | LCE2A interactions | 1.95e-04 | 69 | 33 | 3 | int:LCE2A | |
| Interaction | VSTM4 interactions | 2.01e-04 | 13 | 33 | 2 | int:VSTM4 | |
| Interaction | ATN1 interactions | 2.38e-04 | 187 | 33 | 4 | int:ATN1 | |
| Interaction | GLRX3 interactions | 2.58e-04 | 191 | 33 | 4 | int:GLRX3 | |
| Interaction | KRTAP4-5 interactions | 2.59e-04 | 76 | 33 | 3 | int:KRTAP4-5 | |
| Interaction | APPBP2 interactions | 2.63e-04 | 192 | 33 | 4 | int:APPBP2 | |
| Interaction | KLF2 interactions | 2.69e-04 | 15 | 33 | 2 | int:KLF2 | |
| Interaction | SLC43A2 interactions | 2.69e-04 | 15 | 33 | 2 | int:SLC43A2 | |
| Interaction | ZNF837 interactions | 2.91e-04 | 79 | 33 | 3 | int:ZNF837 | |
| Interaction | KRTAP4-4 interactions | 3.13e-04 | 81 | 33 | 3 | int:KRTAP4-4 | |
| Interaction | KRTAP5-9 interactions | 3.25e-04 | 203 | 33 | 4 | int:KRTAP5-9 | |
| Interaction | POU4F2 interactions | 3.36e-04 | 83 | 33 | 3 | int:POU4F2 | |
| Interaction | MAML2 interactions | 3.48e-04 | 17 | 33 | 2 | int:MAML2 | |
| Interaction | USP2-AS1 interactions | 3.48e-04 | 17 | 33 | 2 | int:USP2-AS1 | |
| Interaction | NMU interactions | 3.61e-04 | 85 | 33 | 3 | int:NMU | |
| Interaction | XPA interactions | 3.73e-04 | 86 | 33 | 3 | int:XPA | |
| Interaction | GUCD1 interactions | 3.99e-04 | 88 | 33 | 3 | int:GUCD1 | |
| Interaction | ADAMTSL4 interactions | 4.19e-04 | 217 | 33 | 4 | int:ADAMTSL4 | |
| Interaction | KRTAP1-1 interactions | 4.34e-04 | 219 | 33 | 4 | int:KRTAP1-1 | |
| Interaction | NEUROG1 interactions | 4.37e-04 | 19 | 33 | 2 | int:NEUROG1 | |
| Interaction | RAB40A interactions | 4.37e-04 | 19 | 33 | 2 | int:RAB40A | |
| Interaction | KRTAP4-11 interactions | 4.55e-04 | 92 | 33 | 3 | int:KRTAP4-11 | |
| Interaction | KRTAP10-8 interactions | 4.56e-04 | 401 | 33 | 5 | int:KRTAP10-8 | |
| Interaction | KRTAP5-6 interactions | 4.84e-04 | 94 | 33 | 3 | int:KRTAP5-6 | |
| Interaction | SPIB interactions | 4.85e-04 | 20 | 33 | 2 | int:SPIB | |
| Interaction | ZNF786 interactions | 5.36e-04 | 21 | 33 | 2 | int:ZNF786 | |
| Interaction | HOXB4 interactions | 5.36e-04 | 21 | 33 | 2 | int:HOXB4 | |
| Interaction | PLAGL1 interactions | 5.36e-04 | 21 | 33 | 2 | int:PLAGL1 | |
| Interaction | KLF13 interactions | 5.36e-04 | 21 | 33 | 2 | int:KLF13 | |
| Interaction | CITED4 interactions | 5.36e-04 | 21 | 33 | 2 | int:CITED4 | |
| Interaction | NUFIP2 interactions | 5.45e-04 | 417 | 33 | 5 | int:NUFIP2 | |
| Interaction | KRTAP9-8 interactions | 5.80e-04 | 100 | 33 | 3 | int:KRTAP9-8 | |
| Interaction | IL1A interactions | 5.88e-04 | 22 | 33 | 2 | int:IL1A | |
| Interaction | PRKCD interactions | 5.93e-04 | 238 | 33 | 4 | int:PRKCD | |
| Interaction | KRTAP10-9 interactions | 6.22e-04 | 241 | 33 | 4 | int:KRTAP10-9 | |
| Interaction | CHRNG interactions | 6.44e-04 | 23 | 33 | 2 | int:CHRNG | |
| Interaction | CITED2 interactions | 6.44e-04 | 23 | 33 | 2 | int:CITED2 | |
| Interaction | HOXD10 interactions | 6.44e-04 | 23 | 33 | 2 | int:HOXD10 | |
| Interaction | CNTN2 interactions | 7.02e-04 | 24 | 33 | 2 | int:CNTN2 | |
| Interaction | NR6A1 interactions | 7.02e-04 | 24 | 33 | 2 | int:NR6A1 | |
| Interaction | TFAP2B interactions | 7.02e-04 | 24 | 33 | 2 | int:TFAP2B | |
| Interaction | TBX21 interactions | 7.02e-04 | 24 | 33 | 2 | int:TBX21 | |
| Interaction | WDR59 interactions | 7.46e-04 | 109 | 33 | 3 | int:WDR59 | |
| Interaction | ZDHHC1 interactions | 7.62e-04 | 25 | 33 | 2 | int:ZDHHC1 | |
| Interaction | ALX1 interactions | 7.62e-04 | 25 | 33 | 2 | int:ALX1 | |
| Interaction | SFRP1 interactions | 7.62e-04 | 25 | 33 | 2 | int:SFRP1 | |
| Interaction | SPRY1 interactions | 7.87e-04 | 111 | 33 | 3 | int:SPRY1 | |
| Interaction | YY1 interactions | 8.00e-04 | 454 | 33 | 5 | int:YY1 | |
| Interaction | HOXB7 interactions | 8.25e-04 | 26 | 33 | 2 | int:HOXB7 | |
| Interaction | SLC23A1 interactions | 8.25e-04 | 26 | 33 | 2 | int:SLC23A1 | |
| Interaction | TRADD interactions | 8.28e-04 | 113 | 33 | 3 | int:TRADD | |
| Interaction | IKBKG interactions | 8.32e-04 | 458 | 33 | 5 | int:IKBKG | |
| Interaction | PCK1 interactions | 9.62e-04 | 119 | 33 | 3 | int:PCK1 | |
| Interaction | NPRL2 interactions | 1.01e-03 | 121 | 33 | 3 | int:NPRL2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.74e-06 | 473 | 36 | 6 | chr17q21 | |
| Cytoband | 17q12-q21 | 2.16e-06 | 32 | 36 | 3 | 17q12-q21 | |
| GeneFamily | Keratin associated proteins | 6.39e-07 | 109 | 28 | 5 | 619 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.67e-06 | 18 | 28 | 3 | 91 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.10e-04 | 17 | 28 | 2 | 486 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 6.25e-04 | 24 | 28 | 2 | 76 | |
| GeneFamily | WD repeat domain containing | 7.54e-03 | 262 | 28 | 3 | 362 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 133 | 36 | 4 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 4.49e-06 | 137 | 36 | 4 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.78e-06 | 146 | 36 | 4 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 182 | 36 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 182 | 36 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 184 | 36 | 4 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| Drug | AC1ND2OB | 2.40e-06 | 265 | 34 | 6 | CID004568637 | |
| Drug | Velcade (bortezomib | 1.72e-05 | 374 | 34 | 6 | CID000093860 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 2.16e-05 | 5 | 34 | 2 | ctd:C575894 | |
| Drug | phorbol acetate myristate | GRN TNFRSF1A ITGB4 CREBBP EP300 KRTAP1-5 NFKBIE KRTAP1-1 KRTAP1-3 TGFA | 2.50e-05 | 1399 | 34 | 10 | CID000004792 |
| Drug | teleocidin B | 3.32e-05 | 123 | 34 | 4 | CID000072425 | |
| Drug | N-methylmesoporphyrin | 3.36e-05 | 42 | 34 | 3 | CID000444708 | |
| Disease | Menke-Hennekam syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 9.99e-07 | 2 | 30 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 9.99e-07 | 2 | 30 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 1.43e-04 | 100 | 30 | 3 | C0010606 | |
| Disease | glomerulonephritis (is_marker_for) | 1.69e-04 | 19 | 30 | 2 | DOID:2921 (is_marker_for) | |
| Disease | Lung Injury | 2.07e-04 | 21 | 30 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 2.07e-04 | 21 | 30 | 2 | C2350344 | |
| Disease | Renal glomerular disease | 2.49e-04 | 23 | 30 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.49e-04 | 23 | 30 | 2 | C4521256 | |
| Disease | Carcinoma, Transitional Cell | 7.99e-04 | 41 | 30 | 2 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLVHACQCRNANCSL | 1741 | Q09472 | |
| CCQLPHAVCCEDRQH | 466 | P28799 | |
| HACQCRNANCSLPSC | 1781 | Q92793 | |
| CQHQFCRSCWEQHCS | 156 | O95376 | |
| CCQHLGILCLCSRCS | 301 | Q9C0C7 | |
| NECVACNCNLHARRC | 336 | O95631 | |
| HRCFQSCQAHACSVC | 1031 | Q9H0B3 | |
| NCIHTCNCHNGAFCS | 711 | Q96KG7 | |
| LHVACQRQHLACARC | 331 | O00221 | |
| QLTHALACRHCGSSC | 21 | Q5VYM1 | |
| NCELCHSVHVCTRCM | 991 | Q92824 | |
| HLSCFCCCVCERQLQ | 116 | Q8TE12 | |
| CHVLTQATACRTCHR | 211 | Q8TDT2 | |
| HSCSVSSCCRPQCCH | 41 | G5E9R7 | |
| PSCCQLHHAEASCCR | 141 | Q07627 | |
| PTCCQLHHAEASCCR | 131 | Q8IUG1 | |
| SCCQLHHAEASCCRP | 86 | P0C5Y4 | |
| PSCCQLHHAQASCCR | 141 | Q9BYS1 | |
| CECGRCHCHQQSLYT | 596 | P16144 | |
| ALCTVHCSHQNMNCR | 501 | Q13535 | |
| VSCVAHLTCIFCHCS | 681 | Q6ZSI9 | |
| CRLAQTCKLLSQHCC | 301 | Q9UKA2 | |
| HVACCCGNILCHCFN | 286 | P51795 | |
| QCTACTCSGHANICH | 1056 | Q5VV63 | |
| RCCCIAVCAHQCLRL | 546 | Q99698 | |
| CRVCQCLHNLTAHCS | 1986 | A2VEC9 | |
| FECNVLCRCSDHCRN | 116 | Q53H47 | |
| CYNCRCHHHQCIRCS | 921 | Q9ULL8 | |
| ITCVLIHCCQVRKHC | 116 | P01135 | |
| PLRSLHCHVCNCCVA | 436 | Q8IUH4 | |
| TCHLCRKAFTQCSHL | 201 | A8MWA4 | |
| ACHLCRKAFTQCSHL | 201 | A8MUZ8 | |
| ARTHHCSICNRCVLK | 166 | Q969W1 | |
| HLCQECFDSCCHLSH | 256 | Q8NEG5 | |
| WCCHVSCRNCTHTRV | 351 | P04628 | |
| CHRCASMCAVCHHVV | 736 | Q96S15 | |
| ASENHLRHCLSCSKC | 91 | P19438 |